Floatz logo

Microcrystalline cellulose

Insomnia Due to Medical Condition

Vedic Lifesciences Pvt. Ltd.N/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Insomnia Due to Medical Condition cohort.

Asset / SponsorPhaseRating
Eszopiclone
University of California, Los Angeles
Phase 4A
Suvorexant
Mayo Clinic
Phase 4BBB
LEMBOREXANT
YangPan
Phase 4BBB
Cipralex
University of California, Los Angeles
Phase 4BBB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
University of California, San Diego
Phase 3BB

View all 40 →

Same molecule, other indications

Microcrystalline cellulose is also rated in:

ObesityDormant
B
Indicative ·
56 / 100
View asset →
diabetic neuropathyDormant
D
Indicative ·
30 / 100
View asset →
obesity disorderDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →